Intradermal Influenza Vaccination
Characterization of Immune Response to Intradermal Influenza Vaccination
Sponsor: Chan Zuckerberg Initiative
A EARLY_PHASE1 clinical study on Vaccine Reaction, this trial is actively recruiting participants. The trial is conducted by Chan Zuckerberg Initiative and has accumulated 7 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Jul 2025 — Present [monthly]
Recruiting EARLY_PHASE1
-
Sep 2024 — Jul 2025 [monthly]
Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting EARLY_PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Feb 2024 — Apr 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
▶ Show 2 earlier versions
-
Dec 2023 — Feb 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Nov 2023 — Dec 2023 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Chan Zuckerberg Initiative
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Silicon Valley Community Foundation
- University of Chicago
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .